Cytek Biosciences, Inc. (CTKB) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.1
Day's range
$4.41

Cytek BioSciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 17.17 M $86.72 M   3.78% 13.46%
VANGUARD GROUP INC 01/29/2026 7.48 M $37.75 M   7.82% 5.86%
TOPLINE CAPITAL MANAGEMENT, LLC 02/17/2026 7.44 M $37.58 M   7.17% 5.84%
HHLR ADVISORS, LTD. 02/17/2026 6.66 M $33.62 M   0.00% 5.22%
BOSTON PARTNERS 02/13/2026 5.01 M $25.30 M   13,369.35% 3.93%
MILLENNIUM MANAGEMENT LLC 02/17/2026 4.75 M $24.00 M   39.03% 3.73%
STATE STREET CORP 02/13/2026 4.15 M $20.94 M   1.53% 3.25%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.79 M $14.10 M   0.26% 2.19%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 2.65 M $13.37 M   -17.74% 2.08%
BROWN CAPITAL MANAGEMENT LLC 02/17/2026 2.07 M $10.47 M   -58.19% 1.63%
GOLDMAN SACHS GROUP INC 03/25/2026 1.79 M $9.04 M   3.03% 1.40%
MORGAN STANLEY 02/13/2026 1.70 M $8.59 M   16.26% 1.33%
ROYCE & ASSOCIATES LP 02/09/2026 1.69 M $8.55 M   -4.00% 1.33%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.09 M $5.53 M   -0.95% 0.86%
RUSSELL INVESTMENTS GROUP, LTD. 02/17/2026 1.00 M $5.06 M   527.61% 0.78%
NORTHERN TRUST CORP 02/17/2026 957.59 K $4.84 M   -5.52% 0.75%
BANK OF AMERICA CORP /DE/ 02/17/2026 856.16 K $4.32 M   403.15% 0.67%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 764.28 K $3.86 M   -69.92% 0.60%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 743.46 K $3.75 M   -27.10% 0.58%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 675.00 K $3.41 M   -15.15% 0.53%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 674.48 K $3.40 M   19.26% 0.53%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 666.93 K $3.37 M   7.00% 0.52%
BANK OF NEW YORK MELLON CORP 02/10/2026 637.93 K $3.22 M   -5.29% 0.50%
UBS GROUP AG 01/29/2026 460.05 K $2.32 M   -1.84% 0.36%
HRT FINANCIAL LP 02/12/2026 437.65 K $2.21 M   100.00% 0.34%
INVESCO LTD. 02/19/2026 398.80 K $2.01 M   2.49% 0.31%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/13/2026 379.27 K $1.92 M   -11.14% 0.30%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 361.68 K $1.83 M   0.11% 0.28%
JPMORGAN CHASE & CO 02/11/2026 328.85 K $1.66 M   -8.33% 0.26%
02/04/2026 298.46 K $1.51 M   100.00% 0.23%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 295.64 K $1.49 M   -0.75% 0.23%
AMERICAN CENTURY COMPANIES INC 02/13/2026 284.64 K $1.44 M   2.76% 0.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 264.18 K $1.33 M   -67.96% 0.21%
D. E. SHAW & CO., INC. 02/17/2026 263.13 K $1.33 M   117.42% 0.21%
NUVEEN, LLC 02/12/2026 253.81 K $1.28 M   0.00% 0.20%
RHUMBLINE ADVISERS 02/13/2026 249.94 K $1.26 M   -10.85% 0.20%
FMR LLC 02/17/2026 234.07 K $1.18 M   29.47% 0.18%
AMERIPRISE FINANCIAL INC 02/17/2026 202.32 K $1.02 M   -38.44% 0.16%
LEGAL & GENERAL GROUP PLC 02/09/2026 188.47 K $951.76 K   -2.03% 0.15%
NUMERAI GP LLC 02/17/2026 186.76 K $943.16 K   75.37% 0.15%
BARCLAYS PLC 02/13/2026 183.24 K $925.36 K   10.67% 0.14%
STATE OF WISCONSIN INVESTMENT BOARD 02/17/2026 168.56 K $851.24 K   -50.16% 0.13%
CITADEL ADVISORS LLC 02/17/2026 166.75 K $842.11 K   102.61% 0.13%
ALLIANCEBERNSTEIN L.P. 02/17/2026 141.05 K $712.29 K   -5.75% 0.11%
WELLS FARGO & COMPANY/MN 02/13/2026 132.68 K $670.01 K   46.76% 0.10%
IEQ CAPITAL, LLC 02/13/2026 123.99 K $626.16 K   -18.87% 0.10%
CREATIVE PLANNING 02/17/2026 121.21 K $612.11 K   11.58% 0.10%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 114.26 K $576.99 K   -39.10% 0.09%
PRUDENTIAL FINANCIAL INC 02/13/2026 106.86 K $539.63 K   -5.16% 0.08%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 106.28 K $536.72 K   346.26% 0.08%

Cytek BioSciences Inc institutional Ownership - FAQ's

During the previous two years, 187 institutional investors and hedge funds held shares of Cytek BioSciences Inc. The most heavily invested institutionals were:

Boston Partners: 5.8 M

DIMENSIONAL FUND ADVISORS LP: 2.66 M

ROYCE & ASSOCIATES LP: 1.64 M

Russell Investments Group, Ltd.: 1.36 M

CenterBook Partners LP: 729,874

VANGUARD FIDUCIARY TRUST CO: 717,011

64.31% of Cytek BioSciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 101.84 M shares in the last 24 months. This purchase volume represents approximately $444.03 M in transactions.